Korro Bio (KRRO) Interest Coverage Ratio Growth (3y) (2021 - 2026)
Korro Bio (KRRO) Interest Coverage Ratio Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 29.47% |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | 76.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.66% |
| Dec 31, 2025 | -239.00% |
| Sep 30, 2025 | 71.18% |
| Jun 30, 2025 | 69.82% |
| Mar 31, 2025 | -90.39% |
| Dec 31, 2024 | -25.22% |
| Sep 30, 2024 | 44.56% |
| Jun 30, 2024 | 21.97% |
| Mar 31, 2024 | -402.01% |
| Dec 31, 2023 | -108.91% |
| Sep 30, 2023 | -4,209.04% |
| Jun 30, 2023 | -2,233.99% |
| Mar 31, 2023 | -847.14% |
| Dec 31, 2022 | -427.36% |
| Sep 30, 2022 | -729.35% |
| Dec 31, 2021 | 37.65% |
| Sep 30, 2021 | 71.28% |